atenolol has been researched along with Benign Neoplasms in 13 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Association between the use of reserpine and breast cancer in women, between atenolol and some types of cancer in elderly men also can not be ruled out." | 4.81 | [Antihypertensive drugs and malignant neoplasia]. ( Kiktev, VG; Preobrazhenskiĭ, DV; Sidorenko, BA; Stetsenko, TM, 2002) |
| "Atenolol treatment reduced REE by 77+/-14 kcal/day and propranolol by 48+/-13 kcal/day, respectively (P<0." | 2.69 | Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. ( Daneryd, P; Hyltander, A; Körner, U; Lundholm, K; Sandström, R, 2000) |
| "The association between diuretics and renal cell carcinoma was analysed in 4389 cases and 6566 controls, yielding a pooled OR of 1." | 2.41 | Antihypertensive therapy and the risk of malignancies. ( Goldbourt, U; Grossman, E; Messerli, FH, 2001) |
| "Observed numbers of cancers in clinic patients were compared with expected numbers derived from cancer rates in two control populations adjusted for age, sex, and time period of data collection." | 1.29 | Incidence of and mortality from cancer in hypertensive patients. ( Gillis, CR; Hawthorne, VM; Hole, DJ; Isles, CG; Lever, AF; McGhee, SM; Robertson, JW; Wapshaw, JA, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Choi, E | 1 |
| Lee, C | 1 |
| Park, JE | 1 |
| Seo, JJ | 1 |
| Cho, M | 1 |
| Kang, JS | 1 |
| Kim, HM | 1 |
| Park, SK | 1 |
| Lee, K | 1 |
| Han, G | 1 |
| Dolusić, E | 1 |
| Larrieu, P | 1 |
| Moineaux, L | 1 |
| Stroobant, V | 1 |
| Pilotte, L | 1 |
| Colau, D | 1 |
| Pochet, L | 1 |
| Van den Eynde, B | 1 |
| Masereel, B | 1 |
| Wouters, J | 1 |
| Frédérick, R | 1 |
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Friedman, GD | 1 |
| Udaltsova, N | 1 |
| Habel, LA | 1 |
| Monami, M | 1 |
| Filippi, L | 1 |
| Ungar, A | 1 |
| Sgrilli, F | 1 |
| Antenore, A | 1 |
| Dicembrini, I | 1 |
| Bagnoli, P | 1 |
| Marchionni, N | 1 |
| Rotella, CM | 1 |
| Mannucci, E | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Sidorenko, BA | 1 |
| Stetsenko, TM | 1 |
| Kiktev, VG | 1 |
| Gould, S | 1 |
| Westwood, FR | 1 |
| Curwen, JO | 1 |
| Ashton, SE | 1 |
| Roberts, DW | 1 |
| Lovick, SC | 1 |
| Ryan, AJ | 1 |
| Hole, DJ | 1 |
| Hawthorne, VM | 1 |
| Isles, CG | 1 |
| McGhee, SM | 1 |
| Robertson, JW | 1 |
| Gillis, CR | 1 |
| Wapshaw, JA | 1 |
| Lever, AF | 1 |
| Fletcher, AE | 1 |
| Beevers, DG | 1 |
| Bulpitt, CJ | 1 |
| Coles, EC | 1 |
| Dollery, CT | 1 |
| Ledingham, JG | 1 |
| Palmer, AJ | 1 |
| Petrie, JC | 1 |
| Webster, J | 1 |
| Hyltander, A | 1 |
| Daneryd, P | 1 |
| Sandström, R | 1 |
| Körner, U | 1 |
| Lundholm, K | 1 |
| Möllhoff, T | 1 |
| Buerkle, H | 1 |
| Van Aken, H | 1 |
| Brodner, G | 1 |
| Grossman, E | 1 |
| Messerli, FH | 1 |
| Goldbourt, U | 1 |
5 reviews available for atenolol and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabet | 2013 |
[Antihypertensive drugs and malignant neoplasia].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Age Factors; Aged; Angiotensin-Converting | 2002 |
[Efficacy of oncologic surgery. Does anesthesia influence the postoperative outcome?].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Bisoprolol; Clin | 2001 |
Antihypertensive therapy and the risk of malignancies.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aten | 2001 |
2 trials available for atenolol and Benign Neoplasms
| Article | Year |
|---|---|
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabet | 2013 |
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Cachexia; Calorimetry, Indirect; Carbohydrate Metabolism; Ene | 2000 |
7 other studies available for atenolol and Benign Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Membrane Permeability; Compute | 2011 |
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; | 2011 |
Norepinephrine antagonists and cancer risk.
Topics: Atenolol; Breast Neoplasms; Clonidine; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Meto | 2011 |
Effect of pretreatment with atenolol and nifedipine on ZD6126-induced cardiac toxicity in rats.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Antineoplasti | 2007 |
Incidence of and mortality from cancer in hypertensive patients.
Topics: Age Factors; Antihypertensive Agents; Atenolol; Female; Humans; Hypertension; Incidence; Male; Middl | 1993 |
Cancer mortality and atenolol treatment.
Topics: Atenolol; England; Female; Humans; Hypertension; Male; Middle Aged; Neoplasms; Risk Factors | 1993 |